摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-tert-butyldimethylsilyloxynaphthalen-1-yl)-3-(2-methylphenyl)-3-(4-methylpiperazin-1-yl)-2-propen-1-one | 1219684-06-6

中文名称
——
中文别名
——
英文名称
1-(2-tert-butyldimethylsilyloxynaphthalen-1-yl)-3-(2-methylphenyl)-3-(4-methylpiperazin-1-yl)-2-propen-1-one
英文别名
——
1-(2-tert-butyldimethylsilyloxynaphthalen-1-yl)-3-(2-methylphenyl)-3-(4-methylpiperazin-1-yl)-2-propen-1-one化学式
CAS
1219684-06-6
化学式
C31H40N2O2Si
mdl
——
分子量
500.756
InChiKey
NYAWPHUHJLSNTD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.0
  • 重原子数:
    36.0
  • 可旋转键数:
    6.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    32.78
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    1-(2-tert-butyldimethylsilyloxynaphthalen-1-yl)-3-(2-methylphenyl)-3-(4-methylpiperazin-1-yl)-2-propen-1-one 作用下, 以 二甲基亚砜 为溶剂, 反应 9.5h, 以84%的产率得到1-(2-hydroxynaphthalen-1-yl)-3-(2-methylphenyl)-3-(4-methylpiperazin-1-yl)-2-propen-1-one
    参考文献:
    名称:
    β-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: Improvement of solubility by disruption of molecular planarity
    摘要:
    The physiological role of aryl hydrocarbon receptor (AhR) is not yet fully understood, and investigation is hampered by the limited solubility of reported AhR ligands in aqueous media. To achieve improved solubility, we focused on our previous finding that planarity-disruption of molecules leads to less efficient crystal packing and greater aqueous solubility. Here, we describe chemical modification of an AhR agonist, beta-naphthoflavone, focusing on planarity-disruption. As expected, introduction of substituents at the ortho-positions of the phenyl group resulted in greater solubility. Among the compounds prepared, the fluoro analog showed more potent AhR agonistic activity and greater solubility than did b-naphthoflavone. Our results indicate that this strategy to improve aqueous solubility, that is, introduction of substituent(s) that disrupt planarity, may be generally applicable to bicyclic molecules. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.12.036
  • 作为产物:
    描述:
    N-甲基哌嗪1-(2-tert-butyldimethylsilyloxynaphthalen-1-yl)-3-(2-methylphenyl)-2-propyn-1-one乙醇 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 2.0h, 以58%的产率得到1-(2-tert-butyldimethylsilyloxynaphthalen-1-yl)-3-(2-methylphenyl)-3-(4-methylpiperazin-1-yl)-2-propen-1-one
    参考文献:
    名称:
    β-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: Improvement of solubility by disruption of molecular planarity
    摘要:
    The physiological role of aryl hydrocarbon receptor (AhR) is not yet fully understood, and investigation is hampered by the limited solubility of reported AhR ligands in aqueous media. To achieve improved solubility, we focused on our previous finding that planarity-disruption of molecules leads to less efficient crystal packing and greater aqueous solubility. Here, we describe chemical modification of an AhR agonist, beta-naphthoflavone, focusing on planarity-disruption. As expected, introduction of substituents at the ortho-positions of the phenyl group resulted in greater solubility. Among the compounds prepared, the fluoro analog showed more potent AhR agonistic activity and greater solubility than did b-naphthoflavone. Our results indicate that this strategy to improve aqueous solubility, that is, introduction of substituent(s) that disrupt planarity, may be generally applicable to bicyclic molecules. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.12.036
点击查看最新优质反应信息

同类化合物

([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) (R)-斯替戊喷酯-d9 (E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E)-3-(4-(叔丁基)苯基)丙烯酸乙酯 (E)-3-(2-(三氟甲基)苯基)丙烯酸乙酯 (E)-3-(2,4-二甲氧基苯基)丙烯酸乙酯 (E/Z)-他莫昔芬-d5 (5Z)-7-氧杂烯醇 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S,5R,5''R)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4R,5S)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4-甲氧基-6-[(E)-2-(3-甲氧基苯基)乙烯基]-5,6-二氢-2H-吡 (2Z)-1,3-二苯基-2-丙烯-1-酮,2-丙烯-1-酮,1,3-二苯基-,(2Z)- (2E)-N-[2-(3-羟基-2-氧代-2,3-二氢-1H-吲哚-3-基)乙基]-3-苯基丙-2-烯酰胺 (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 (11aR)-3,7-双(3,5-二甲基苯基)-10,11,12,13-四氢-5-羟基-5-氧化物-二茚基[7,1-de:1'',7''-fg][1,3,2]二氧杂膦酸 龙血素D 龙血素C 龙血素A 龙血素 B 龙血树脂红血树脂 鼠李素 鼠李柠檬素3-O-beta-D-鼠李三糖苷 鼠李柠檬素 鼠李亭3-O-beta-吡喃葡萄糖苷 鼓槌石斛素 黄麦格霉素 黄金树苷 黄酮醇-2-磺酸钠盐 黄酮胺 黄酮榕碱 黄酮地洛 黄酮哌酯 黄酮 黄豆黄苷 黄豆黄素 黄豆苷元-D6 黄豆苷元-4,7-二葡糖苷 黄诺马甙 黄苏木素 黄花夹竹桃黄酮 黄芪总皂甙 黄芪异黄烷苷,7,2'-二羟基-3',4'-二甲氧基异黄烷 黄芩黄酮II 黄芩黄酮I 黄芩黄酮 黄芩苷甲酯 黄芩苷 黄芩素磷酸酯